In addition, we analyzed the oncogenicity of FXR in CRC, firstly we screened for effective knockdown of siRNAs of FXR by Western blotting and qPCR, and the results indicated that siFXR-3 significantly knocked down the expression of FXR (Figures 3B, C). This evidence concerns the gene NR1H4 and colorectal carcinoma.